These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18661356)

  • 1. Molecular profile of the BCL2 family of the apoptosis related genes in breast cancer cells after treatment with cytotoxic/cytostatic drugs.
    Thomadaki H; Scorilas A
    Connect Tissue Res; 2008; 49(3):261-4. PubMed ID: 18661356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12.
    Thomadaki H; Scorilas A
    Ann N Y Acad Sci; 2007 Jan; 1095():35-44. PubMed ID: 17404015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer.
    Thomadaki H; Talieri M; Scorilas A
    Cancer Lett; 2007 Mar; 247(1):48-55. PubMed ID: 16647810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review).
    Navolanic PM; Steelman LS; McCubrey JA
    Int J Oncol; 2003 Feb; 22(2):237-52. PubMed ID: 12527919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2 family members as molecular targets in cancer therapy.
    Marzo I; Naval J
    Biochem Pharmacol; 2008 Oct; 76(8):939-46. PubMed ID: 18638457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional roles of Fli-1, a member of the Ets family of transcription factors, in human breast malignancy.
    Sakurai T; Kondoh N; Arai M; Hamada J; Yamada T; Kihara-Negishi F; Izawa T; Ohno H; Yamamoto M; Oikawa T
    Cancer Sci; 2007; 98(11):1775-84. PubMed ID: 17727680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer drug development based on modulation of the Bcl-2 family core apoptosis mechanism.
    Gardner CR
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):1157-77. PubMed ID: 15606340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.
    Tabuchi Y; Matsuoka J; Gunduz M; Imada T; Ono R; Ito M; Motoki T; Yamatsuji T; Shirakawa Y; Takaoka M; Haisa M; Tanaka N; Kurebayashi J; Jordan VC; Naomoto Y
    Int J Oncol; 2009 Feb; 34(2):313-9. PubMed ID: 19148464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial zinc(II) complexes regulate cell cycle and apoptosis-related genes in tumor cell lines.
    Gao J; Liu YG; Zhou Y; Boxer LM; Woolley FR; Zingaro RA
    Chembiochem; 2007 Feb; 8(3):332-40. PubMed ID: 17203500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Se-methylselenocysteine sensitized TRAIL-mediated apoptosis via down-regulation of Bcl-2 expression.
    Lee JT; Lee TJ; Park JW; Kwon TK
    Int J Oncol; 2009 May; 34(5):1455-60. PubMed ID: 19360359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-cadherin decreased human breast cancer cells sensitivity to staurosporine by up-regulating Bcl-2 expression.
    Wang L; Li Z; Wang C; Yang Y; Sun L; Yao W; Cai X; Wu G; Zhou F; Zha X
    Arch Biochem Biophys; 2009 Jan; 481(1):116-22. PubMed ID: 18983973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topotecan and methotrexate alter expression of the apoptosis-related genes BCL2, FAS and BCL2L12 in leukemic HL-60 cells.
    Floros KV; Talieri M; Scorilas A
    Biol Chem; 2006 Dec; 387(12):1629-33. PubMed ID: 17132110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-kappaB and Bcl-2.
    Ahmad A; Banerjee S; Wang Z; Kong D; Sarkar FH
    J Cell Biochem; 2008 Dec; 105(6):1461-71. PubMed ID: 18980240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular response of HL-60 cells to mitotic inhibitors vincristine and taxol visualized with apoptosis-related gene expressions, including the new member BCL2L12.
    Thomadaki H; Floros KV; Scorilas A
    Ann N Y Acad Sci; 2009 Aug; 1171():276-83. PubMed ID: 19723066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of hypoxia-induced apoptosis of human breast cancer cells via STAT5b by momilactone B.
    Joung YH; Lim EJ; Kim MS; Lim SD; Yoon SY; Lim YC; Yoo YB; Ye SK; Park T; Chung IM; Bae KY; Yang YM
    Int J Oncol; 2008 Sep; 33(3):477-84. PubMed ID: 18695876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New advances in the second-line treatment of small cell lung cancer.
    Hurwitz JL; McCoy F; Scullin P; Fennell DA
    Oncologist; 2009 Oct; 14(10):986-94. PubMed ID: 19819917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosing and exploiting cancer's addiction to blocks in apoptosis.
    Letai AG
    Nat Rev Cancer; 2008 Feb; 8(2):121-32. PubMed ID: 18202696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular profile of breast versus ovarian cancer cells in response to treatment with the anticancer drugs cisplatin, carboplatin, doxorubicin, etoposide and taxol.
    Thomadaki H; Scorilas A
    Biol Chem; 2008 Nov; 389(11):1427-34. PubMed ID: 18783338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional down-regulation of Bcl-2 by vinorelbine: identification of a novel binding site of p53 on Bcl-2 promoter.
    Bourgarel-Rey V; Savry A; Hua G; Carré M; Bressin C; Chacon C; Imbert J; Braguer D; Barra Y
    Biochem Pharmacol; 2009 Nov; 78(9):1148-56. PubMed ID: 19555669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanisms on apoptosis by inhibiting VEGF expression in human breast cancer cells.
    Ge YL; Zhang X; Zhang JY; Hou L; Tian RH
    Int Immunopharmacol; 2009 Apr; 9(4):389-95. PubMed ID: 19162240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.